Wuhan YZY Biopharma Co., Ltd. (2496.HK)

7.450 0.000 (0.00%) At close: 03:46PM HKT

Wuhan YZY Biopharma Co., Ltd.

Building C2-1, Optics Valley Biocity
No. 666 Gaoxin Avenue East Lake New Technology Development Zone
Wuhan 430075
China
86 27 8266 8988
https://www.yzybio.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 123

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Pengfei Zhou / Ph.D., M.D.	Chairman of the Board & CEO	2.67M	N/A	1967
Dr. Jizu Yi	Senior Vice President of Quality	N/A	N/A	1963
Mr. Jing Zhang	Senior Director of the R&D Center and Supervisor	N/A	N/A	1983
Mr. Jianhua Zheng	Senior Manager of Strategic Development Department & Joint Company Secretary	N/A	N/A	N/A
Ms. Tin Yun Lai	Joint Company Secretary	N/A	N/A	1989

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

Wuhan YZY Biopharma Co., Ltd., a biotechnology company, develops bispecific antibody-based therapies for the treatment of cancer, cancer-related complications, and age-related eye diseases. It develops various product candidates for the treatment of malignant ascites, malignant pleural effusion, solid tumors, pancreatic cancer, hepatocellular carcinoma and other advanced solid tumors, small cell lung cancer, relapsed/refractory multiple myeloma, and HER2-positive solid tumors; and covid 19 indication, as well as wAMD, DME, and other ocular neovascularization-related diseases. The company was founded in 2010 and is based in Wuhan, China.

Corporate governance

Wuhan YZY Biopharma Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.